相似文献
1
2
Proceedings: Effect of amantadine on the urinary excretion of some monoamines and metabolites in normal and parkinsonian subjects.
Br J Pharmacol. 1972 Feb;44(2):386P-387P.
3
Urinary excretion of dopamine and homovanillic acid during L-dopa treatment of Parkinson's disease.
Isr J Med Sci. 1972 May;81(5):597-601.
4
Effect of amantadine on the urinary excretion of some monoamines and metabolites in normal and Parkinsonian subjects.
J Neurol Sci. 1972 Nov;17(3):245-53. doi: 10.1016/0022-510x(72)90030-5.
5
Urinary monoamine metabolite excretion in disorders of movement. Effects of amantadine and levodopa.
J Neurol Sci. 1977 Jun;32(2):219-25. doi: 10.1016/0022-510x(77)90237-4.
6
Separation and determination of urinary homovanillic acid and iso-homovanillic acid by gas-liquid chromatography and electron capture detection.
J Lab Clin Med. 1973 Nov;82(5):829-35.
7
Iso-homovanillic acid determination in cerebrospinal fluid and in urine during L-DOPA treatment of Parkinson's disease.
Clin Chim Acta. 1973 Nov 15;48(4):427-31. doi: 10.1016/0009-8981(73)90422-1.
8
Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5HIAA) during L-dopa therapy of Parkinson's disease.
Neurology. 1970 Apr;20(4):377.
9
Metabolic patterns and clinical response to levedopa therapy in Parkinson's disease.
Clin Pharmacol Ther. 1973 Jul-Aug;14(4):565-71. doi: 10.1002/cpt1973144part1565.
10
Treatment of Parkinson's disease with amantadine and L-Dopa.
Eur Neurol. 1972;7(4):228-40. doi: 10.1159/000114429.
Zotero 插件